Lindbrook Capital, LLC - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$743
-7.2%
140
+66.7%
0.00%
Q2 2023$801
-73.3%
84
-39.1%
0.00%
-100.0%
Q3 2022$3,0000.0%138
+9.5%
0.00%
Q2 2022$3,000
+50.0%
126
+8.6%
0.00%
Q1 2022$2,0001160.00%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 10,542,790$314,175,00035.62%
Bain Capital Life Sciences Investors, LLC 3,979,292$118,583,00020.06%
Omega Fund Management, LLC 844,680$25,171,00010.42%
Vivo Capital, LLC 1,686,527$50,259,0004.55%
Orbimed Advisors 4,673,850$139,281,0002.34%
RA Capital Management 1,165,184$34,722,0001.10%
Polar Capital LLP 375,000$11,175,0000.12%
CAAS CAPITAL MANAGEMENT LP 22,413$668,0000.07%
FMR LLC 5,713,343$170,258,0000.02%
Laurion Capital Management LP 50,000$1,490,0000.02%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders